Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-kappaB activation in gastric

X H Jiang1, B C Wong, M C Lin

  • 1Department of Gastroenterology, Rui-jin Hospital, Shanghai, Peoples Republic of China.

Oncogene
|December 26, 2001
PubMed

Insights

Triptolide, derived from Tripterygium wilfordii Hook f, inhibits gastric cancer cell growth and induces apoptosis. Its anti-tumor effects are dependent on a functional p53 protein, highlighting a key mechanism for potential cancer therapies.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Triptolide, a compound from Tripterygium wilfordii Hook f (TWHf), shows promise as an anti-neoplastic agent.
  • Gastric cancer remains a significant health concern, necessitating novel therapeutic strategies.
  • The role of p53 in cancer cell response to natural compounds is an area of active research.

Purpose of the Study:

  • To investigate the therapeutic potential and underlying mechanisms of triptolide against human gastric cancer cells.
  • To determine the influence of p53 status on triptolide's efficacy in gastric cancer.
  • To elucidate triptolide's effects on cell proliferation, apoptosis, and key signaling pathways.

Main Methods:

  • Utilized four human gastric cancer cell lines with varying p53 statuses (wild-type and mutant).
  • Assessed triptolide's impact on cell growth inhibition and apoptosis induction.
  • Investigated effects on NF-kappaB and AP-1 transactivation, p53, p21(waf1/cip1), and bax protein expression, caspase activity, and cell cycle progression.
  • Employed antisense oligonucleotide and dominant-negative p53 to examine p53's role.

Main Results:

  • Triptolide inhibited cell growth and induced apoptosis in gastric cancer cells with wild-type p53 (AGS, MKN-45).
  • Triptolide suppressed NF-kappaB and AP-1 transactivation, upregulated p53, p21(waf1/cip1), and bax, increased caspase activity, and caused G(0)/G(1) cell cycle arrest.
  • Apoptosis induction and NF-kappaB inhibition by triptolide were abrogated upon p53 suppression, confirming p53's essential role.
  • Triptolide showed limited efficacy in gastric cancer cells with mutant p53 (MKN-28, SGC-7901).

Conclusions:

  • Triptolide exhibits anti-tumor and anti-inflammatory effects in gastric cancer cells by inhibiting proliferation and inducing apoptosis.
  • A functional p53 protein is crucial for mediating triptolide's pro-apoptotic, anti-inflammatory, and anti-tumor activities.
  • Triptolide's differential efficacy based on p53 status suggests its potential as a targeted therapy for gastric cancers with functional p53.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.